Page last updated: 2024-10-27

fenoldopam and Chronic Kidney Diseases

fenoldopam has been researched along with Chronic Kidney Diseases in 2 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Research Excerpts

ExcerptRelevanceReference
" We aimed to investigate by color-Doppler ultrasonography the effects of IV administration of FM at this dosage in hypertensive chronic kidney disease (CKD) patients, and verify whether it may induce any systemic hemodynamic alteration."1.51Effects of fenoldopam on renal blood flow in hypertensive chronic kidney disease. ( Busca, A; Casasco, M; Di Daniele, N; Ferrannini, M; Manca di Villahermosa, S; Marrone, G; Noce, A; Rovella, V; Sorge, R; Tesauro, M, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rovella, V1
Ferrannini, M1
Tesauro, M1
Marrone, G1
Busca, A1
Sorge, R1
Manca di Villahermosa, S1
Casasco, M1
Di Daniele, N1
Noce, A1
Teirstein, PS1
Price, MJ1
Mathur, VS1
Madyoon, H1
Sawhney, N1
Baim, DS1

Trials

1 trial available for fenoldopam and Chronic Kidney Diseases

ArticleYear
Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization.
    The American journal of cardiology, 2006, Apr-01, Volume: 97, Issue:7

    Topics: Aged; Blood Pressure; Cardiac Catheterization; Cross-Over Studies; Drug Delivery Systems; Female; Fe

2006

Other Studies

1 other study available for fenoldopam and Chronic Kidney Diseases

ArticleYear
Effects of fenoldopam on renal blood flow in hypertensive chronic kidney disease.
    Journal of nephrology, 2019, Volume: 32, Issue:1

    Topics: Aged; Antihypertensive Agents; Arterial Pressure; Blood Flow Velocity; Female; Fenoldopam; Humans; H

2019